TY  - CHAP
M1  - Book, Section
TI  - Preface
A1  - Weiss, Robert A.
A1  - Weiss, Margaret A.
A1  - Beasley, Karen L.
PY  - 2012
T2  - Sclerotherapy and Vein Treatment, 2e
AB  - In  the  first  edition  of  this  textbook,  we  lamented  medicine’s  extremely  low  level  of  priority  given  to  venous  disease.  There  has  been  a  huge  turn  around  in  the  last  decade,  however,  as  awareness  of  venous  disease  and  improved  treatment  techniques  have  grown  tremendously.  Several  reasons  account  for  this  shift.  The  abandonment  of  ligation  and  stripping,  with  the  adoption  of  minimally  invasive  endovenous  ablation  techniques  for  treatment  of  saphenous  disease  have  been  primary  driving  forces  in  the  rapid  surge  of  venous  treatment.  More  patients  are  willing  to  undergo  straightforward  ambulatory  procedures  rather  than  stripping  to  attain  long-term  improvement  of  leg  pain  and  appearance.  Availability  of  safer  sclerosing  agents  such  as  polidocanol  has  also  contributed  to  greatly  increased  interest  by  physicians  and  patients.  
SN  - 
PB  - McGraw Hill LLC
CY  - New York, NY
Y2  - 2024/04/20
UR  - dermatology.mhmedical.com/content.aspx?aid=1172746742
ER  -